Related Experiment Video
Updated: Mar 7, 2026

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
Small genomic insertions form enhancers that misregulate oncogenes
Brian J Abraham1, Denes Hnisz1, Abraham S Weintraub1,2
1Whitehead Institute for Biomedical Research, 455 Main Street, Cambridge, Massachusetts 02142, USA.
Abstract:
The non-coding regions of tumour cell genomes harbour a considerable fraction of total DNA sequence variation, but the functional contribution of these variants to tumorigenesis is ill-defined. Among these non-coding variants, somatic insertions are among the least well characterized due to challenges with interpreting short-read DNA sequences. Here, using a combination of Chip-seq to enrich enhancer DNA and a computational approach with multiple DNA alignment procedures, we identify enhancer-associated small insertion variants. Among the 102 tumour cell genomes we analyse, small insertions are frequently observed in enhancer DNA sequences near known oncogenes. Further study of one insertion, somatically acquired in primary leukaemia tumour genomes, reveals that it nucleates formation of an active enhancer that drives expression of the LMO2 oncogene. The approach described here to identify enhancer-associated small insertion variants provides a foundation for further study of these abnormalities across human cancers.
Insights
Researchers identified small insertion variants in non-coding DNA, specifically near oncogenes. One insertion created an active enhancer, driving LMO2 oncogene expression in leukemia, offering new insights into cancer development.
Area of Science:
- Genomics
- Cancer Biology
- Molecular Oncology
Background:
- Non-coding DNA variations contribute to tumorigenesis but their functional roles are unclear.
- Somatic insertions in non-coding regions are poorly understood due to sequencing challenges.
Purpose of the Study:
- To develop a method for identifying enhancer-associated small insertion variants.
- To investigate the functional impact of these variants in human cancers.
Main Methods:
- Utilized ChIP-seq (Chromatin Immunoprecipitation sequencing) to enrich for enhancer DNA.
- Employed computational analysis with multiple DNA alignment procedures.
- Analyzed 102 tumor cell genomes.
Main Results:
- Identified frequent small insertions in enhancer DNA near known oncogenes.
- Discovered a somatic insertion in leukemia genomes that forms an active enhancer.
- This enhancer drives the expression of the LMO2 oncogene.
Conclusions:
- The developed approach effectively identifies enhancer-associated small insertion variants.
- These variants can functionally contribute to tumorigenesis by altering oncogene expression.
- Provides a basis for studying these abnormalities in various human cancers.
Related Concept Videos
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Induced Pluripotent Stem Cells
Somatic...
Non-LTR Retrotransposons
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

